Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Article
  • Published:

RNAi suppresses polyglutamine-induced neurodegeneration in a model of spinocerebellar ataxia

Abstract

The dominant polyglutamine expansion diseases, which include spinocerebellar ataxia type 1 (SCA1) and Huntington disease, are progressive, untreatable, neurodegenerative disorders. In inducible mouse models of SCA1 and Huntington disease, repression of mutant allele expression improves disease phenotypes. Thus, therapies designed to inhibit expression of the mutant gene would be beneficial. Here we evaluate the ability of RNA interference (RNAi) to inhibit polyglutamine-induced neurodegeneration caused by mutant ataxin-1 in a mouse model of SCA1. Upon intracerebellar injection, recombinant adeno-associated virus (AAV) vectors expressing short hairpin RNAs profoundly improved motor coordination, restored cerebellar morphology and resolved characteristic ataxin-1 inclusions in Purkinje cells of SCA1 mice. Our data demonstrate in vivo the potential use of RNAi as therapy for dominant neurodegenerative disease.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Figure 1: Silencing ataxin-1.
Figure 2: AAV vectors for shRNA expression in vivo.
Figure 3: SCA1 neuropathology is improved by shRNAs directed to ataxin-1.
Figure 4: RNAi reduces intranuclear inclusions in transduced cells.

Similar content being viewed by others

Accession codes

Accessions

GenBank/EMBL/DDBJ

References

  1. Orr, H.T. et al. Expansion of an unstable trinucleotide CAG repeat in spinocerebellar ataxia type 1. Nat. Genet. 4, 221–226 (1993).

    Article  CAS  Google Scholar 

  2. Zoghbi, H.Y. & Orr, H.T. Spinocerebellar ataxia type 1. Semin. Cell Biol. 6, 29–35 (1995).

    Article  CAS  Google Scholar 

  3. Skinner, P.J. et al. Ataxin-1 with an expanded glutamine tract alters nuclear matrix-associated structures. Nature 389, 971–234 (1997).

    Article  CAS  Google Scholar 

  4. Fernandez-Funez, P. et al. Identification of genes that modify ataxin-1-induced neurodegeneration. Nature 408, 101–106 (2000).

    Article  CAS  Google Scholar 

  5. Burright, E.N. et al. SCA1 transgenic mice: a model for neurodegeneration caused by an expanded CAG trinucleotide repeat. Cell 82, 937–948 (1995).

    Article  CAS  Google Scholar 

  6. Klement, I.A. et al. Ataxin-1 nuclear localization and aggregation: role in polyglutamine-induced disease in SCA1 transgenic mice. Cell 95, 41–53 (1998).

    Article  CAS  Google Scholar 

  7. Emamian, E.S. et al. Serine 776 of ataxin-1 is critical for polyglutamine-induced disease in SCA1 transgenic mice. Neuron 38, 375–387 (2003).

    Article  CAS  Google Scholar 

  8. Chen, H.K. et al. Interaction of Akt-phosphorylated ataxin-1 with 14-3-3 mediates neurodegeneration in spinocerebellar ataxia type 1. Cell 113, 457–468 (2003).

    Article  CAS  Google Scholar 

  9. Cummings, C.J. et al. Chaperone suppression of aggregation and altered subcellular proteasome localization imply protein misfolding in Sca1. Nat. Genet. 19, 148–154 (1998).

    Article  CAS  Google Scholar 

  10. Caplen, N.J. et al. Rescue of polyglutamine-mediated cytotoxicity by double-stranded RNA-mediated RNA interference. Hum. Mol. Genet. 11, 175–184 (2002).

    Article  CAS  Google Scholar 

  11. Miller, V.M. et al. Allele-specific silencing of dominant disease genes. Proc. Natl. Acad. Sci. USA 100, 7195–7200 (2003).

    Article  CAS  Google Scholar 

  12. Xia, H., Mao, Q., Paulson, H.L. & Davidson, B.L. siRNA-mediated gene silencing in vitro and in vivo. Nat. Biotechnol. 20, 1006–1010 (2002).

    Article  CAS  Google Scholar 

  13. Davidson, B.L. & Paulson, H.L. Molecular medicine for the brain: silencing disease genes with RNA interference. Lancet Neurol. 3, 145–149 (2004).

    Article  CAS  Google Scholar 

  14. Pittman, R.N., Wang, S., DiBenedetto, A.J. & Mills, J.C. A system for characterizing cellular and molecular events in programmed neuronal cell death. J. Neurosci. 13, 3669–3680 (1993).

    Article  CAS  Google Scholar 

  15. Kawasaki, H. & Taira, K. Short hairpin type of dsRNAs that are controlled by tRHAVal promoter significantly induce RNAi-mediated gene silencing in the cytoplasm of human cells. Nucleic Acids Res. 31, 700–707 (2003).

    Article  CAS  Google Scholar 

  16. Clark, H.B. et al. Purkinje cell expression of a mutant allele of SCA1 in transgenic mice leads to disparate effects on motor behaviors, followed by a progressive cerebellar dysfunction and histological alterations. J. Neurosci. 17, 7385–7395 (1997).

    Article  CAS  Google Scholar 

  17. Alisky, J. et al. Transduction of murine cerebellar neurons with recombinant FIV and AAV5 vectors. Neuroreport 11, 2669–2673 (2000).

    Article  CAS  Google Scholar 

  18. Diener, H.-C. & Dichgans, J. Cerebellar and spinocerebellar gait disorders. in Clinical Disorders of Balance, Posture and Gait (eds. Bronstein, A.M., Brandt, T. & Woollacott, M.) 147–155 (Oxford University Press, 1996).

    Google Scholar 

  19. Stenoien, D.L., Mielke, M. & Mancini, M.A. Intranuclear ataxin1 inclusions contain both fast- and slow-exchanging components. Nat. Cell Biol. 4, 806–810 (2002).

    Article  CAS  Google Scholar 

  20. Chai, Y., Shao, J., Miller, V.M., Williams, A. & Paulson, H.L. Live-cell imaging reveals divergent intracellular dynamics of polyglutamine disease proteins and supports a sequestration model of pathogenesis. Proc. Natl. Acad. Sci. USA 99, 9310–9315 (2002).

    Article  CAS  Google Scholar 

  21. Khvorova, A., Reynolds, A. & Jayasena, S.D. Functional siRNAs and miRNAs exhibit strand bias. Cell 115, 505 (2003).

    Article  CAS  Google Scholar 

  22. Reynolds, A. et al. Rational siRNA design for RNA interference. Nat. Biotechnol. 22, 326–330 (2004).

    Article  CAS  Google Scholar 

  23. Urabe, M., Ding, C. & Kotin, R.M. Insect cells as a factory to produce adeno-associated virus type 2 vectors. Hum. Gene Ther. 13, 1935–1943 (2002).

    Article  CAS  Google Scholar 

  24. Miyagishi, M. & Taira, K. U6 promoter-driven siRNAs with four uridine 3′ overhangs efficiently suppress targeted gene expression in mammalian cells. Nat. Biotechnol. 20, 497–500 (2002).

    Article  CAS  Google Scholar 

  25. Williams, R.W. & Rakic, P. Three-dimensional counting: an accurate and direct method to estimate numbers of cells in sectioned material. J. Comp. Neurol. 278, 344–352 (1988).

    Article  CAS  Google Scholar 

Download references

Acknowledgements

We thank C. McLennan, J. Critchfield, S. Ries, N. Kiewiet and X. He for assistance. This work was supported by the National Institutes of Health (B.L.D., H.L.P. and H.T.O.), the Hereditary Disease Foundation (B.L.D., H.L.P. and S.Q.H.) and the Roy J. Carver Charitable Trust (B.L.D.).

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Beverly L Davidson.

Ethics declarations

Competing interests

B.L.D. is a consultant for Sirna Therapeutics, Inc. and serves on the Scientific Advisory Board of Oxford BioMedica.

Supplementary information

Supplementary Fig. 1

Effects of shSCA1.F10mi and shSCA1.F11mi on ataxin-1 expression in mice cerebella. (PDF 125 kb)

Supplementary Fig. 2

Reductions in ataxin-1 inclusions in SCA1 mice requires transduction. (PDF 79 kb)

Rights and permissions

Reprints and permissions

About this article

Cite this article

Xia, H., Mao, Q., Eliason, S. et al. RNAi suppresses polyglutamine-induced neurodegeneration in a model of spinocerebellar ataxia. Nat Med 10, 816–820 (2004). https://doi.org/10.1038/nm1076

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/nm1076

This article is cited by

Search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing